TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
- PMID: 16891318
- DOI: 10.1093/brain/awl205
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
Abstract
NKG2D ligands (NKG2DL) are expressed by infected and transformed cells. They transmit danger signals to NKG2D-expressing immune cells, leading to lysis of NKG2DL-expressing cells. We here report that the NKG2DL MHC class I-chain-related molecules A and B (MICA/B) and UL16-binding proteins (ULBP) 1-3 are expressed in human brain tumours in vivo, while expression levels are low or undetectable in normal brain. MICA and ULBP2 expression decrease with increasing WHO grade of malignancy, while MICB and ULBP1 are expressed independently of tumour grade. We further delineate two independent mechanisms that can explain these expression patterns: (i) transforming growth factor-beta (TGF-beta) is upregulated during malignant progression and selectively downregulates MICA, ULBP2 and ULBP4 expression, while MICB, ULBP1 and ULBP3 are unaffected. (ii) Cleavage of MICA and ULBP2 is reduced by inhibition of metalloproteinases (MP), whereas no changes in the expression levels of other NKG2DL were detected. Consequently, NKG2DL-dependent NK cell-mediated lysis is enhanced by depletion of TGF-beta or inhibition of MP. Thus, escape from NKG2D-mediated immune surveillance of malignant gliomas in vivo may be promoted by the inhibition of MICA and ULBP2 expression via an autocrine TGF-beta loop and by MP-dependent shedding from the cell surface. Loss of MICA and ULBP2, in contrast to other NKG2DL, may be particularly important in glioma immune escape, and differential regulation of human NKG2DL expression is part of the immunosuppressive properties of human malignant glioma cells.
Similar articles
-
Proteolytic release of soluble UL16-binding protein 2 from tumor cells.Cancer Res. 2006 Mar 1;66(5):2520-6. doi: 10.1158/0008-5472.CAN-05-2520. Cancer Res. 2006. PMID: 16510567
-
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.Cancer Res. 2002 Nov 1;62(21):6178-86. Cancer Res. 2002. PMID: 12414645
-
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21. Cell Immunol. 2006. PMID: 16630603
-
Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):159-70. doi: 10.1016/j.cytogfr.2007.01.013. Epub 2007 Feb 26. Cytokine Growth Factor Rev. 2007. PMID: 17324607 Review.
-
UL16 binding proteins.Immunobiology. 2004;209(3):283-90. doi: 10.1016/j.imbio.2004.04.008. Immunobiology. 2004. PMID: 15518340 Review.
Cited by
-
Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches.Cancer Control. 2024 Jan-Dec;31:10732748241290067. doi: 10.1177/10732748241290067. Cancer Control. 2024. PMID: 39353594 Free PMC article. Review.
-
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.Front Immunol. 2023 May 15;14:1157100. doi: 10.3389/fimmu.2023.1157100. eCollection 2023. Front Immunol. 2023. PMID: 37256148 Free PMC article.
-
Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity.Oncoimmunology. 2012 Sep 1;1(6):884-893. doi: 10.4161/onci.20637. Oncoimmunology. 2012. PMID: 23162756 Free PMC article.
-
The Paradoxical Role of NKG2D in Cancer Immunity.Front Immunol. 2018 Aug 13;9:1808. doi: 10.3389/fimmu.2018.01808. eCollection 2018. Front Immunol. 2018. PMID: 30150983 Free PMC article. Review.
-
Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.PLoS One. 2013 Jul 26;8(7):e70063. doi: 10.1371/journal.pone.0070063. Print 2013. PLoS One. 2013. PMID: 23922903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials